Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
Takanori Mizoguchi,1 Mineo Ozaki,2 Nobuchika Ogino3 1Mizoguchi Eye Clinic, Ophthalmology, Sasebo, Japan; 2Ozaki Eye Hospital, Ophthalmology, Miyazaki, Japan; 3Nishigaki Eye Clinic, Ophthalmology, Nagoya, Japan Purpose: To evaluate the efficacy and safety of 0.05% epinastine and 0.1% olopatadine ey...
Guardado en:
Autores principales: | Mizoguchi T, Ozaki M, Ogino N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bbb1fa0597144a6599e344fca39bab0a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
por: McLaurin E, et al.
Publicado: (2017) -
Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
por: Azadeh Dorostkar, et al.
Publicado: (2021) -
Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies
por: Meier E, et al.
Publicado: (2017) -
Size-Segregated Particulate Matter Down to PM<sub>0.1</sub> and Carbon Content during the Rainy and Dry Seasons in Sumatra Island, Indonesia
por: Muhammad Amin, et al.
Publicado: (2021) -
Prevalencia de síntomas de rinitis alérgica y su relación con factores de riesgo en escolares de Santiago, Chile
por: Caussade L,Solange, et al.
Publicado: (2006)